These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 1358772
1. High-risk acute lymphoblastic leukemia (ALL): is there an alternative approach for increasing the number of cures? Carella AM. Haematologica; 1992; 77(4):348-51. PubMed ID: 1358772 [No Abstract] [Full Text] [Related]
2. Idarubicin plus ARA-C followed by allogeneic or autologous bone marrow transplantation in advanced acute lymphoblastic leukemia. Arcese W, Meloni G, Giona F, Vegna ML, Testi AM, Annino L, Iori AP, Carotenuto M, Resegotti L, Madon E. Bone Marrow Transplant; 1991; 7 Suppl 2():38. PubMed ID: 1878711 [No Abstract] [Full Text] [Related]
3. TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission. Biagi E, Rovelli A, Balduzzi A, De Lorenzo P, Tagliabue A, Uderzo C. Bone Marrow Transplant; 2000 Dec; 26(11):1260-2. PubMed ID: 11149746 [No Abstract] [Full Text] [Related]
4. [Autotransplantation in acute leukemia using totipotent cells mobilized with filgrastim]. Ruiz-Argüelles GJ, Ruiz-Argüelles A, Alemán-Hoey DD, Arizpe Bravo D, Martin-López A, Ocejo Rodríguez A. Rev Invest Clin; 1993 Dec; 45(5):479-80. PubMed ID: 7510900 [No Abstract] [Full Text] [Related]
5. Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children. Horstmann MA, Hassenpflug WA, zur Stadt U, Escherich G, Janka G, Kabisch H. Haematologica; 2005 Dec; 90(12):1701-3. PubMed ID: 16330449 [Abstract] [Full Text] [Related]
7. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells. Visani G, Lemoli R, Tosi P, Martinelli G, Testoni N, Ricci P, Motta M, Gherlinzoni F, Leopardi G, Pastano R, Rizzi S, Piccaluga P, Isidori A, Tura S. Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929 [Abstract] [Full Text] [Related]
8. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide. Bostrom B, Weisdorf DJ, Kim T, Kersey JH, Ramsay NK. Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007 [Abstract] [Full Text] [Related]
10. [Treatment of acute lymphoblastic leukemia in adults with seven-drug induction therapy and intensive consolidation with or without autologous stem cell transplantation followed by maintenance therapy. Experience of a single center]. Doubek M, Mayer J, Korístek Z, Protivánková M, Brychtová Y, Oborilová A, Král Z, Klabusay M, Tomíska M, Buchtová I, Vorlícek J. Cas Lek Cesk; 2002 Mar 01; 141(4):122-6. PubMed ID: 12046256 [Abstract] [Full Text] [Related]
11. Intensive therapy for adult acute lymphoblastic leukemia: preliminary results of the idarubicin/vincristine/L-asparaginase/prednisolone regimen. Bassan R, Battista R, Viero P, Pogliani E, Rossi G, Lambertenghi-Deliliers G, Rambaldi A, D'Emilio A, Buelli M, Borleri G. Semin Oncol; 1993 Dec 01; 20(6 Suppl 8):39-46. PubMed ID: 7507263 [Abstract] [Full Text] [Related]
14. Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study. Choi SJ, Lee JH, Lee JH, Kim S, Lee YS, Seol M, Ryu SG, Lee JS, Kim WK, Jang S, Park CJ, Chi HS, Lee KH. Bone Marrow Transplant; 2005 Jul 01; 36(2):163-9. PubMed ID: 15937507 [Abstract] [Full Text] [Related]
15. [Preliminary treatment results of relapsed or refractory acute leukemia using two and three drug regimens]. Mariańska B, Apel D, Seferyńska I, Maj S. Wiad Lek; 1998 Jul 01; 51(1-2):42-5. PubMed ID: 9608830 [Abstract] [Full Text] [Related]
18. High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity. van Besien K, Tabocoff J, Rodriguez M, Andersson B, Mehra R, Przepiorka D, Dimopoulos M, Giralt S, Suki S, Khouri I. Bone Marrow Transplant; 1995 Apr 01; 15(4):549-55. PubMed ID: 7655380 [Abstract] [Full Text] [Related]